| Serial Number | 79380032 |
| Word Mark | NORDICPRO-C6 |
| Filing Date | Wednesday, July 19, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 9, 2025 |
| Registration Number | 7933249 |
| Registration Date | Tuesday, September 9, 2025 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 22, 2025 |
| Goods and Services | diagnostic biomarker reagents for medical and clinical purposes; diagnostic biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; diagnostic biomarker assays to identify disease activity; medical diagnostic biomarker assays to quantify disease activity; medical diagnostic biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; medical diagnostic test strips for research and diagnostic use for protein fragment detection, disease detection, disease analysis and quantifying disease activity; diagnostic preparations for medical purposes; diagnostic agents for medical use |
| Goods and Services | custom design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; custom design and development of biochemical, pharmaceutical, and medical assays; custom design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical and scientific research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysis, namely, analysis of pharmacodynamic data; biological research and analysis, namely, analysis of data relating to biomarkers; development services in the field of diagnostic preparations, equipment and tests; medical and scientific research, namely, conducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes namely diagnostic testing services; medical research laboratory services; research laboratory services in the fields of medical and pharmaceutical research; advice, information and assistance relating to the foregoing |
| Pseudo Mark | NORDIC PRO C SIX |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 6, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 6, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Nordic Bioscience A/S |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Party Name | Nordic Bioscience A/S |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Party Name | Nordic Bioscience A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Event Date | Event Description |
| Thursday, October 5, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, October 6, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 10, 2023 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 25, 2024 | ASSIGNED TO EXAMINER |
| Thursday, May 2, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, May 3, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, May 8, 2024 | REFUSAL PROCESSED BY MPU |
| Wednesday, May 8, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, May 27, 2024 | REFUSAL PROCESSED BY IB |
| Tuesday, November 5, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 4, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, March 4, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, March 22, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, June 17, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 17, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 17, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 17, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, June 17, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 16, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 22, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 22, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 9, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 9, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, December 9, 2025 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |